News
19h
Fintel on MSNWilliam Blair Downgrades MaxCyte (MXCT)Fintel reports that on August 7, 2025, William Blair downgraded their outlook for MaxCyte (NasdaqGS:MXCT) from Outperform to ...
BellRing Brands, Inc. (NYSE:BRBR) is one of the top oversold NYSE stocks to buy now. William Blair analyst Jon Andersen ...
CBIZ, Inc. (NYSE:CBZ) is one of the top oversold NYSE stocks to buy now. On July 24, William Blair analyst Andrew Nicholas ...
1d
Fintel on MSNWilliam Blair Upgrades JBT Marel (JBTM)Fintel reports that on August 6, 2025, William Blair upgraded their outlook for JBT Marel (NYSE:JBTM) from Market Perform to ...
Exact Sciences beat Q2 expectations, raised its 2025 forecast, and secured U.S. rights to Freenome's CRC blood tests in a ...
On Thursday, Eli Lilly and Co.’s (NYSE:LLY) weight loss rival Novo Nordisk A/S (NYSE:NVO), along with smaller firms, Terns ...
Elanco Animal Health Incorporated (NYSE:ELAN) reported second-quarter 2025 results on Thursday, posting adjusted earnings per ...
Clarivate Plc (NYSE:CLVT) is one of the Best Undervalued UK Stocks to Buy According to Analysts. On July 31, William Blair ...
Sarepta did not hold an investor call for its second-quarter earnings report or provide an updated full-year revenue outlook.
Arista Networks’ management is eager to tap into VeloCloud’s channel program opportunities that analysts have cited as ripe ...
Carronade Capital has been advocating for the separation of Viasat’s Defense and Advanced Technologies segment, arguing it could be one of the most attractive pure-play defense technology platforms in ...
William Blair analyst Louie DiPalma upgraded ViaSat stock to "outperform" today. DiPalma thinks a spinoff and a big cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results